Director Shareholding

GlaxoSmithKline PLC 04 August 2003 Directors' Interests I give below details of changes in directors' interests in the Ordinary Shares of GlaxoSmithKline plc. 31 July 2003 Abacus (GSK) Trustees Limited, as trustee of the GlaxoSmithKline Employee Trust, ("the GSK Trust"), transferred 3,158 Ordinary Shares in the Company on behalf of participants in the Glaxo Wellcome International Share Option Plan. 31 July 2003 The GSK Trust transferred 3,519 Ordinary Shares in the Company on behalf of participants in the Glaxo Group Option Plan. 31 July 2003 The GSK Trust sold 4,050 Ordinary Shares in the Company on behalf of participants in the SmithKline Beecham Mid Term Incentive Plan at a price of £11.86 per share. 31 July 2003 The GSK Trust transferred 10,310 Ordinary Shares in the Company on behalf of participants in the SmithKline Beecham Mid Term Incentive Plan. 31 July 2003 The GSK Trust transferred 22,038 Ordinary Shares in the Company to participants in the SmithKline Beecham Employee Share Option Plan 1991. 1 August 2003 The GSK Trust transferred 3,022 Ordinary Shares in the Company to participants in the SmithKline Beecham Employee Share Option Plan 1991. The Company was advised of these transactions on 1 August 2003 and 4 August 2003. The GSK Trust is a discretionary trust of which all employees or former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Two of the Company's directors, Dr J-P Garnier and Mr J D Coombe are therefore interested in the shares held in the GSK Trust from time to time in the same way as other employees or former employees of GlaxoSmithKline plc and its subsidiaries. S M Bicknell Company Secretary 4 August 2003 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings